The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial - Voors, Adriaan A.; Angermann, Christiane E.; Teerlink, John R.; Collins, Sean P.; Kosiborod, Mikhail; Biegus, Jan; Ferreira, João Pedro; Nassif, Michael E.; Psotka, Mitchell A.; Tromp, Jasper; Borleffs, C. Jan Willem; Ma, Changsheng; et al. (Nature medicine, 2022)
Gesehen am 06.05.2024